Amygdalar neurotransmission alterations in the BTBR mice model of idiopathic autism

Abstract Autism Spectrum Disorders (ASD) are principally diagnosed by three core behavioural symptoms, such as stereotyped repertoire, communication impairments and social dysfunctions. This complex pathology has been linked to abnormalities of corticostriatal and limbic circuits. Despite experiment...

Full description

Bibliographic Details
Main Authors: Maria Bove, Maria Adelaide Palmieri, Martina Santoro, Lisa Pia Agosti, Silvana Gaetani, Adele Romano, Stefania Dimonte, Giuseppe Costantino, Vladyslav Sikora, Paolo Tucci, Stefania Schiavone, Maria Grazia Morgese, Luigia Trabace
Format: Article
Language:English
Published: Nature Publishing Group 2024-04-01
Series:Translational Psychiatry
Online Access:https://doi.org/10.1038/s41398-024-02905-z
_version_ 1797199227650048000
author Maria Bove
Maria Adelaide Palmieri
Martina Santoro
Lisa Pia Agosti
Silvana Gaetani
Adele Romano
Stefania Dimonte
Giuseppe Costantino
Vladyslav Sikora
Paolo Tucci
Stefania Schiavone
Maria Grazia Morgese
Luigia Trabace
author_facet Maria Bove
Maria Adelaide Palmieri
Martina Santoro
Lisa Pia Agosti
Silvana Gaetani
Adele Romano
Stefania Dimonte
Giuseppe Costantino
Vladyslav Sikora
Paolo Tucci
Stefania Schiavone
Maria Grazia Morgese
Luigia Trabace
author_sort Maria Bove
collection DOAJ
description Abstract Autism Spectrum Disorders (ASD) are principally diagnosed by three core behavioural symptoms, such as stereotyped repertoire, communication impairments and social dysfunctions. This complex pathology has been linked to abnormalities of corticostriatal and limbic circuits. Despite experimental efforts in elucidating the molecular mechanisms behind these abnormalities, a clear etiopathogenic hypothesis is still lacking. To this aim, preclinical studies can be really helpful to longitudinally study behavioural alterations resembling human symptoms and to investigate the underlying neurobiological correlates. In this regard, the BTBR T+ Itpr3tf/J (BTBR) mice are an inbred mouse strain that exhibits a pattern of behaviours well resembling human ASD-like behavioural features. In this study, the BTBR mice model was used to investigate neurochemical and biomolecular alterations, regarding Nerve Growth Factor (NGF) and Brain-Derived Neurotrophic Factor (BDNF), together with GABAergic, glutamatergic, cholinergic, dopaminergic and noradrenergic neurotransmissions and their metabolites in four different brain areas, i.e. prefrontal cortex, hippocampus, amygdala and hypothalamus. In our results, BTBR strain reported decreased noradrenaline, acetylcholine and GABA levels in prefrontal cortex, while hippocampal measurements showed reduced NGF and BDNF expression levels, together with GABA levels. Concerning hypothalamus, no differences were retrieved. As regarding amygdala, we found reduced dopamine levels, accompanied by increased dopamine metabolites in BTBR mice, together with decreased acetylcholine, NGF and GABA levels and enhanced glutamate content. Taken together, our data showed that the BTBR ASD model, beyond its face validity, is a useful tool to untangle neurotransmission alterations that could be underpinned to the heterogeneous ASD-like behaviours, highlighting the crucial role played by amygdala.
first_indexed 2024-04-24T07:12:24Z
format Article
id doaj.art-efab544c43934ab29813574435abf3a8
institution Directory Open Access Journal
issn 2158-3188
language English
last_indexed 2024-04-24T07:12:24Z
publishDate 2024-04-01
publisher Nature Publishing Group
record_format Article
series Translational Psychiatry
spelling doaj.art-efab544c43934ab29813574435abf3a82024-04-21T11:31:11ZengNature Publishing GroupTranslational Psychiatry2158-31882024-04-0114111010.1038/s41398-024-02905-zAmygdalar neurotransmission alterations in the BTBR mice model of idiopathic autismMaria Bove0Maria Adelaide Palmieri1Martina Santoro2Lisa Pia Agosti3Silvana Gaetani4Adele Romano5Stefania Dimonte6Giuseppe Costantino7Vladyslav Sikora8Paolo Tucci9Stefania Schiavone10Maria Grazia Morgese11Luigia Trabace12Department of Clinical and Experimental Medicine, University of FoggiaDepartment of Clinical and Experimental Medicine, University of FoggiaDepartment of Physiology and Pharmacology “V. Erspamer”, Sapienza University of RomeDepartment of Clinical and Experimental Medicine, University of FoggiaDepartment of Physiology and Pharmacology “V. Erspamer”, Sapienza University of RomeDepartment of Physiology and Pharmacology “V. Erspamer”, Sapienza University of RomeDepartment of Clinical and Experimental Medicine, University of FoggiaDepartment of Clinical and Experimental Medicine, University of FoggiaDepartment of Clinical and Experimental Medicine, University of FoggiaDepartment of Clinical and Experimental Medicine, University of FoggiaDepartment of Clinical and Experimental Medicine, University of FoggiaDepartment of Clinical and Experimental Medicine, University of FoggiaDepartment of Clinical and Experimental Medicine, University of FoggiaAbstract Autism Spectrum Disorders (ASD) are principally diagnosed by three core behavioural symptoms, such as stereotyped repertoire, communication impairments and social dysfunctions. This complex pathology has been linked to abnormalities of corticostriatal and limbic circuits. Despite experimental efforts in elucidating the molecular mechanisms behind these abnormalities, a clear etiopathogenic hypothesis is still lacking. To this aim, preclinical studies can be really helpful to longitudinally study behavioural alterations resembling human symptoms and to investigate the underlying neurobiological correlates. In this regard, the BTBR T+ Itpr3tf/J (BTBR) mice are an inbred mouse strain that exhibits a pattern of behaviours well resembling human ASD-like behavioural features. In this study, the BTBR mice model was used to investigate neurochemical and biomolecular alterations, regarding Nerve Growth Factor (NGF) and Brain-Derived Neurotrophic Factor (BDNF), together with GABAergic, glutamatergic, cholinergic, dopaminergic and noradrenergic neurotransmissions and their metabolites in four different brain areas, i.e. prefrontal cortex, hippocampus, amygdala and hypothalamus. In our results, BTBR strain reported decreased noradrenaline, acetylcholine and GABA levels in prefrontal cortex, while hippocampal measurements showed reduced NGF and BDNF expression levels, together with GABA levels. Concerning hypothalamus, no differences were retrieved. As regarding amygdala, we found reduced dopamine levels, accompanied by increased dopamine metabolites in BTBR mice, together with decreased acetylcholine, NGF and GABA levels and enhanced glutamate content. Taken together, our data showed that the BTBR ASD model, beyond its face validity, is a useful tool to untangle neurotransmission alterations that could be underpinned to the heterogeneous ASD-like behaviours, highlighting the crucial role played by amygdala.https://doi.org/10.1038/s41398-024-02905-z
spellingShingle Maria Bove
Maria Adelaide Palmieri
Martina Santoro
Lisa Pia Agosti
Silvana Gaetani
Adele Romano
Stefania Dimonte
Giuseppe Costantino
Vladyslav Sikora
Paolo Tucci
Stefania Schiavone
Maria Grazia Morgese
Luigia Trabace
Amygdalar neurotransmission alterations in the BTBR mice model of idiopathic autism
Translational Psychiatry
title Amygdalar neurotransmission alterations in the BTBR mice model of idiopathic autism
title_full Amygdalar neurotransmission alterations in the BTBR mice model of idiopathic autism
title_fullStr Amygdalar neurotransmission alterations in the BTBR mice model of idiopathic autism
title_full_unstemmed Amygdalar neurotransmission alterations in the BTBR mice model of idiopathic autism
title_short Amygdalar neurotransmission alterations in the BTBR mice model of idiopathic autism
title_sort amygdalar neurotransmission alterations in the btbr mice model of idiopathic autism
url https://doi.org/10.1038/s41398-024-02905-z
work_keys_str_mv AT mariabove amygdalarneurotransmissionalterationsinthebtbrmicemodelofidiopathicautism
AT mariaadelaidepalmieri amygdalarneurotransmissionalterationsinthebtbrmicemodelofidiopathicautism
AT martinasantoro amygdalarneurotransmissionalterationsinthebtbrmicemodelofidiopathicautism
AT lisapiaagosti amygdalarneurotransmissionalterationsinthebtbrmicemodelofidiopathicautism
AT silvanagaetani amygdalarneurotransmissionalterationsinthebtbrmicemodelofidiopathicautism
AT adeleromano amygdalarneurotransmissionalterationsinthebtbrmicemodelofidiopathicautism
AT stefaniadimonte amygdalarneurotransmissionalterationsinthebtbrmicemodelofidiopathicautism
AT giuseppecostantino amygdalarneurotransmissionalterationsinthebtbrmicemodelofidiopathicautism
AT vladyslavsikora amygdalarneurotransmissionalterationsinthebtbrmicemodelofidiopathicautism
AT paolotucci amygdalarneurotransmissionalterationsinthebtbrmicemodelofidiopathicautism
AT stefaniaschiavone amygdalarneurotransmissionalterationsinthebtbrmicemodelofidiopathicautism
AT mariagraziamorgese amygdalarneurotransmissionalterationsinthebtbrmicemodelofidiopathicautism
AT luigiatrabace amygdalarneurotransmissionalterationsinthebtbrmicemodelofidiopathicautism